Human Genome Epidemiology Literature Finder
|
Records 1 - 19 (of 19 Records) |
| Query Trace: Adenocarcinoma and Mos[original query] |
|---|
| [Correlation between the efficacy of epidermal growth factor receptor tyrosine kinase inhibitors and EGFR mutations in advanced squamous cell lung cancer]. Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases 2012 May 35 (5): 323-8. Duan Jian-chun, An Tong-tong, Wu Mei-na, Yang Lu, Bai Hua, Wang Zhi-jie, Wang Yu-yan, Zhuo Ming-lei, Zhao Jun, Wang Shu-hang, Wang J |
| Standardized uptake value on (18)F-FDG-PET/CT is a predictor of EGFR T790M mutation status in patients with acquired resistance to EGFR-TKIs. Lung cancer (Amsterdam, Netherlands) 2016 Oct 100 14-9. Yoshida Tatsuya, Tanaka Hirotaka, Kuroda Hiroaki, Shimizu Junichi, Horio Yoshitsugu, Sakao Yukinori, Inaba Yoshitaka, Iwata Hiroshi, Hida Toyoaki, Yatabe Yasus |
| Cytoplasmic expression of estrogen receptor ? may predict poor outcome of EGFR-TKI therapy in metastatic lung adenocarcinoma. Oncology letters 2018 Aug 16 (2): 2382-2390. Ding Xiaosheng, Li Li, Tang CHuanhao, Meng Chao, Xu Weiran, Wei Xing, Guo Ziwei, Zhang Tingting, Fu Yali, Zhang Lingling, Wang Xiangyi, Lin Li, Liang J |
| Lung cancer in never smokers from the Princess Margaret Cancer Centre. Oncotarget 2018 Apr 9 (32): 22559-22570. Korpanty Grzegorz J, Kamel-Reid Suzanne, Pintilie Melania, Hwang David M, Zer Alona, Liu Geoffrey, Leighl Natasha B, Feld Ronald, Siu Lillian L, Bedard Philippe L, Tsao Ming-Sound, Shepherd Frances |
| Oncogenic driver mutations in Swiss never smoker patients with lung adenocarcinoma and correlation with clinicopathologic characteristics and outcome. PloS one 2019 14 (8): e0220691. Grosse Claudia, Soltermann Alex, Rechsteiner Markus, Grosse Alexand |
| Clinical outcomes to pemetrexed-based versus non-pemetrexed-based platinum doublets in patients with KRAS-mutant advanced non-squamous non-small cell lung cancer. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2019 Jul . Ricciuti B, Brambilla M, Cortellini A, De Giglio A, Ficorella C, Sidoni A, Bellezza G, Crinò L, Ludovini V, Baglivo S, Metro G, Chiari |
| Apatinib Monotherapy or Combination Therapy for Non-Small Cell Lung Cancer Patients With Brain Metastases. Oncology research 2019 Oct . Xu Jianping, Liu Xiaoyan, Yang Sheng, Shi Yuank |
| Correlation of circulating tumor DNA EGFR mutation levels with clinical outcomes in patients with advanced lung adenocarcinoma. Chinese medical journal 2021 Sep 134 (20): 2430-2437. Liu Xiang-Liang, Bai Ri-Lan, Chen Xiao, Zhao Yu-Guang, Wang Xu, Ma Ke-Wei, Tian Hui-Min, Han Fu-Jun, Liu Zi-Ling, Yang Lei, Li Wei, Gai Fei, Cui Jiu-W |
| Value and significance of brain radiation therapy during first-line EGFR-TKI treatment in lung adenocarcinoma with EGFR sensitive mutation and synchronous brain metastasis: Appropriate timing and technique. Thoracic cancer 2021 10 12 (23): 3157-3168. Gu Yangchun, Xu Yan, Zhuang Hongqing, Jiang Weijuan, Zhang Hua, Li Xiaofeng, Liu Yonggang, Ma Li, Zhao Dahai, Cheng Yuan, Yu Yan, Liu Ping, Qin Jianwen, Chen Xueqin, Gao Junzhen, Wang Mengzhao, Liang Li, Cao Baosh |
| The Right Treatment Strategy for the Right Patient: A Biomarker-Driven Approach to Neoadjuvant vs. Surgery-First Management of Resectable and Borderline Resectable Pancreatic Cancer. Cancers 2022 7 14 (15): . Nahm Christopher B, Turchini John, Sahni Sumit, Moon Elizabeth, Itchins Malinda, Arena Jennifer, Chou Angela, Colvin Emily K, Howell Viive M, Pavlakis Nick, Clarke Stephen, Samra Jaswinder S, Gill Anthony J, Mittal Anubh |
| Retrospective Survival Analysis of Patients With Resected Pancreatic Ductal Adenocarcinoma and a Germline BRCA or PALB2 Mutation. JCO precision oncology 2022 2 3 1-11. Yu Shun, Agarwal Parul, Mamtani Ronac, Symecko Heather, Spielman Kelsey, O'Hara Mark, O'Dwyer Peter J, Schneider Charles, Teitelbaum Ursina, Nathanson Katherine L, Domchek Susan M, Reiss Kim |
| KRAS G12C Mutant Non-Small Cell Lung Cancer Linked to Female Sex and High Risk of CNS Metastasis: Population-based Demographics and Survival Data From the National Swedish Lung Cancer Registry. Clinical lung cancer 2023 6 . Johan Isaksson, Anders Berglund, Karly Louie, Linda Willén, Arash Hamidian, Anders Edsjö, Fredrik Enlund, Maria Planck, Anders Vikström, Mikael Johansson, Andreas Hallqvist, Gunnar Wagenius, Johan Botli |
| Real-World Treatment Outcomes of MET Exon14 Skipping in Non-small Cell Lung Cancer: GFPC 03-18 Study. Targeted oncology 2023 6 . Hélène Babey, Philippe Jamme, Hubert Curcio, Jean Baptiste Assié, Remi Veillon, Hélène Doubre, Maurice Pérol, Florian Guisier, Eric Huchot, Chantal Decroisette, Lionel Falchero, Romain Corre, Alexis Cortot, Christos Chouaïd, Renaud Descou |
| Efficacy and safety of anti-programmed cell death protein 1 antibody combination therapy in patients with advanced experienced epidermal growth factor receptor-tyrosine kinase inhibitor-resistant lung adenocarcinoma: a retrospective cohort study. Journal of thoracic disease 2023 11 15 (10): 5648-5657. Chang Wan, Yiruo Zhang, Pingping Liu, Xinkuan Mei, Gang Cheng, Jingdan Pang, Sheng Chen, Jianping Xu, Jyoti Malhotra, Hesheng Qian, Yingying |
| TP53 co-mutations in advanced lung adenocarcinoma: comparative bioinformatic analyses suggest ambivalent character on overall survival alongside KRAS, STK11 and KEAP1 mutations. Frontiers in oncology 2024 8 14 1357583. Armin Frille, Myriam Boeschen, Hubert Wirtz, Mathias Stiller, Hendrik Bläker, Maximilian von Laffe |
| Efficacy of epidermal growth factor receptor-tyrosine kinase inhibitor for lung adenosquamous cell carcinoma harboring EGFR mutation: a retrospective study and pooled analysis. Frontiers in oncology 2024 7 14 1354854. Xueming Xia, Wei Du, Yan Zhang, Yanying Li, Min Yu, Yongmei L |
| Mutational characteristics and clinical outcomes for lung adenocarcinoma with EGFR germline mutations. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2024 6 . Kelsey Pan, Jennifer Owens, Yasir Elamin, Charles Lu, Mark Routbort, Jianjun Zhang, Frank Fossella, Marcelo V Negrao, Mehmet Altan, Jenny Pozadzides, Ferdinandos Skoulidis, Anne Tsao, Tina Cascone, John V Heymach, Edwin Ostrin, Xiuning |
| Prognostic implications of combining EGFR-TKIs and radiotherapy in Stage IV lung adenocarcinoma with 19-Del or 21-L858R mutations: A real-world study. Cancer medicine 2024 4 13 (8): e7208. Shuai Liang, Hanyu Wang, Yingyun Zhang, Haixia Tian, Chengming Li, Dong H |
| Adjuvant Modified FOLFIRINOX for Resected Pancreatic Adenocarcinoma (PDAC): Clinical Insights and Genomic Features from a Large Contemporary Cohort. Journal of the National Cancer Institute 2024 10 . Fergus Keane, Catherine O'Connor, Drew Moss, Joanne F Chou, Maria A Perry, Fionnuala Crowley, Parima Saxena, Amelia Chan, Joshua D Schoenfeld, Anupriya Singhal, Wungki Park, Darren Cowzer, Emily Harrold, Anna M Varghese, Imane El Dika, Christopher Crane, James J Harding, Ghassan K Abou-Alfa, T Peter Kingham, Alice C Wei, Kenneth H Yu, Michael I D'Angelica, Vinod P Balachandran, Jeffrey Drebin, William R Jarnagin, Chaitanya Bandlamudi, David Kelsen, Marinela Capanu, Kevin C Soares, Fiyinfolu Balogun, Eileen M O'Reil |
- Page last reviewed:Feb 1, 2024
- Content source: